The neuroprotective effect of minocycline is associated with its ability to interfere with MMP activity including gelatin proteolytic activation (MMP-2 and −9); minocycline reduces brain MMP-9 levels in response to microvessel damage and inflammation during the early stage after stroke [4,5,7,8,10]. Here, MMP2 is linked to Stroke.